Medical Genetics seminars
December 2022
Microglial efferocytosis: Diving into the Alzheimer's Disease gene pool
Carmen Romero-Molina, Francesca Garretti· Icahn School of Medicine at Mount Sinai
Recorded
Genome-wide association studies and functional genomics studies have linked specific cell types, genes, and pathways to Alzheimer’s disease (AD) risk. In particular, AD risk alleles primarily affect the abundance or structure, and thus the activity, of genes expressed in macrophages, strongly implicating microglia (the brain-resident macrophages) in the etiology of AD. These genes converge on pathways (endocytosis/phagocytosis, cholesterol metabolism, and immune response) with critical roles in core macrophage functions such as efferocytosis. Here, we review these pathways, highlighting relevant genes identified in the latest AD genetics and genomics studies, and describe how they may contribute to AD pathogenesis. Investigating the functional impact of AD-associated variants and genes in microglia is essential for elucidating disease risk mechanisms and developing effective therapeutic approaches." https://doi.org/10.1016/j.neuron.2022.10.015
February 2021
Interpretación de variantes en SYNGAP1
Eduardo Perez Palma, PhD· Centro de Genética y Genómica, Universidad del Desarrollo, Santiago (Chile)
Fri, Feb 19 · 06:00 UTC · Online
October 2020
De novo mutations in autism and contributions from sperm mosaicism
Joseph Gleeson· UC San Diego; Rady Children's Institute for Genomic Medicine
Wed, Oct 7 · 05:00 UTC · Online
End of results.